-
December 20, 2011PREVIEW
FDA is currently evaluating a postmarketing report of a patient with multiple sclerosis who died within 24 hours of taking the first dose of...
-
December 19, 2011PREVIEW
In a review of data from the PALLAS and ATHENA trials, dronedarone was associated with an increased risk of serious cardiovascular events, including death,...
-
December 17, 2011PREVIEW
The dose limitation for simvastatin has been increased from 10 mg to 20 mg when coadministered with amiodarone, according to an FDA...
-
December 15, 2011PREVIEW
Results from two recently completed epidemiologic studies assessing the cardiovascular safety of attention-deficit/hyperactivity disorder (ADHD) medications in adults did not show an increased...
-
December 15, 2011PREVIEW
Persistent pulmonary hypertension of the newborn (PPHN) may be associated with use of selective serotonin reuptake inhibitors (SSRIs) by women during pregnancy. However, the data are conflicting...
Pages
